You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
You are reading 1 of 2 free-access articles allowed for 30 days
The official national public health emergency on carbapenemase-producing Enterobacteriaceae (CPE) “continues”, according to the Department of Health (DoH). The Department has raised the ending of the emergency in discussions with the HSE. In April, Minister for Health Simon Harris told the Medical Independent (MI) “the ending of the emergency shouldn’t be in any way viewed as an acceptance by the Department that the issue has been resolved”.
In May, Prof Martin Cormican, who leads the HSE’s antimicrobial resistance and infection control team, informed the CPE expert group at the Health Protection Surveillance Centre (HPSC) it was anticipated the Minister would decide to declare the public health emergency over. “However, there is no confirmation of this and no clear indication of the time frame,” according to the minutes.
HPSC data shows there were 537 patients newly confirmed with CPE in 2018, compared with 433 in 2017. Monthly screens in acute hospitals have increased from 13,062 in June 2018 to 24,676 in June 2019. The Department’s spokesperson told MI several key actions regarding antimicrobial resistance and healthcare associated infections, including CPE, have been accomplished.
“These include an improved HSE governance structure for healthcare-associated infections and antimicrobial resistance, enhanced capacity for infection prevention and control teams, publication of a suite of CPE guidance overseen by the CPE Expert Group, and enhanced surveillance of CPE with a report published monthly.”
In April 2019, Minister Harris announced that €7 million had been allocated for antimicrobial resistance and infection prevention and control in acute hospitals and community care settings. This included €2 million allocated in 2018. The Department’s CPE national public health emergency team has met twice so far in 2019. It was convened after the emergency was declared in October 2017.
The health budget oversight group has suggested the HSE and Department of Health should deploy the...
Potentially counterfeit Covid-19 tests have been offered for sale to Irish individuals and businesses, the Health...
Dr Vincent Maher, Consultant Cardiologist, Tallaght Hospital, Dublin, told delegates that there could be up to...
An update to the Covid-19 vaccination programme as a result of the threat posed by the...
There is “no central collation” of data on Covid-19 staff derogations during the pandemic in either...
Leave a Reply
You must be logged in to post a comment.